For the Inventor, By the Inventor

Enter inventor name

Northbrook, IL, United States of America

Xueqing Wang

USPTO Granted Patents = 41 (Patent Applications = 6)

CIPO Patents = 2 (Patent Applications = 20)

EPO Patents = 18 (Patent Applications = 27)

Average Co-Inventor Count = 9.7

ph-index = 9

Forward Citations = 218(Granted Patents)

Location History:

Evanston, IL (US) (2009 - 2015)
Northbrook, IL (US) (2013 - 2019)
San Carloa, CA (US) (2020)
San Carlos, CA (US) (2020 - 2021)
Sunnyvale, CA (US) (2020 - 2021)

Company Filing History:

Abbvie S.a.r.l.

4. 9 out of 4,179

Abbott Laboratories Corporation

Abbvie Overseas Sarl

where one patent can have more than one assignee

Years Active: 2009-2021

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Cystic Fibrosis

Transmembrane Conductance Regulator

Protein Tyrosine Phosphatase Inhibitors

N-Sulfonylated Pyrazolo

Heteroaryl Substituted Pyridines

Substituted Pyrrolidines

Cannabinoid Receptor Ligands

Chemokine Receptor Antagonists

Prodrug Compounds

Acetamides

Benzamides

Sexual Dysfunction

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2021-04-27),

2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2021-04-20),

3. 10954202 - Protein tyrosine phosphatase inhibitors and methods of use thereof (2021-03-23),

4. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-24),

5. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-24),

6. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2020-11-10),

7. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2020-05-12),

8. 10604515 - Heteroaryl substituted pyridines and methods of use (2020-03-31),

9. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use (2019-10-01),

10. 10399940 - Substituted pyrrolidines and methods of use (2019-09-03),

11. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2019-04-16),

12. 10138227 - Heteroaryl substituted pyridines and methods of use (2018-11-27),

13. 10130622 - Compounds for treatment of cystic fibrosis (2018-11-20),

14. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein (2018-11-06),

15. 10047051 - Substituted pyridines and method of use (2018-08-14),

Title: The Innovative Journey of Xueqing Wang

Introduction: Xueqing Wang, a talented inventor based in Northbrook, IL (US), has made significant contributions to the field of technology and innovation.

Latest Patents: Xueqing Wang holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Xueqing Wang has led groundbreaking projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Xueqing Wang has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life, fostering a culture of creativity and excellence.

Conclusion: Xueqing Wang's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…